Relief Therapeutics Holding AG (RLF) — Cash Flow Reinvestment Rate
Relief Therapeutics Holding AG (RLF) has a Cash Flow Reinvestment Rate of 0.04x as of December 2024, reinvesting CHF14.00K (capex CHF14.00K ) from operating cash flow of CHF359.00K. See Relief Therapeutics Holding AG (RLF) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Relief Therapeutics Holding AG Cash Flow Reinvestment Rate (2006–2006)
Historical reinvestment intensity for Relief Therapeutics Holding AG across 1 annual periods. For the full cash flow conversion analysis, see RLF cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Relief Therapeutics Holding AG (2006–2006)
Year-by-year capital reinvestment analysis for Relief Therapeutics Holding AG. See financial flexibility index of Relief Therapeutics Holding AG to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2006 | 0.21x | CHF474.60K | CHF2.28 Million | CHF474.60K | — |